Innospec Past Earnings Performance

Past criteria checks 4/6

Innospec has been growing earnings at an average annual rate of 16.6%, while the Chemicals industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 9.3% per year. Innospec's return on equity is 11.5%, and it has net margins of 7.7%.

Key information

16.6%

Earnings growth rate

16.2%

EPS growth rate

Chemicals Industry Growth4.3%
Revenue growth rate9.3%
Return on equity11.5%
Net Margin7.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Innospec makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0JAX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,87314432644
30 Jun 241,89415034245
31 Mar 241,93914737443
31 Dec 231,94913937842
30 Sep 231,96512737641
30 Jun 232,01412638940
31 Mar 232,00113036739
31 Dec 221,96413335639
30 Sep 221,86613132940
30 Jun 221,72911630440
31 Mar 221,61610628339
31 Dec 211,4839326237
30 Sep 211,3819224734
30 Jun 211,2708123032
31 Mar 211,1601923131
31 Dec 201,1932923731
30 Sep 201,2733724233
30 Jun 201,3805525935
31 Mar 201,49711726635
31 Dec 191,51311227435
30 Sep 191,51810227135
30 Jun 191,5099226534
31 Mar 191,5059226034
31 Dec 181,4778525533
30 Sep 181,4366025633
30 Jun 181,4056325433
31 Mar 181,3736725032
31 Dec 171,3076224031
30 Sep 171,1918923330
30 Jun 171,0647722928
31 Mar 179668022126
31 Dec 168838121025
30 Sep 168929120826
30 Jun 1694011520526
31 Mar 1695512120226
31 Dec 151,01212020725
30 Sep 151,05711619924
30 Jun 151,03110118824
31 Mar 151,0098517623
31 Dec 149618416922
30 Sep 149128516522
30 Jun 148767815522
31 Mar 148407714821
31 Dec 138197814221

Quality Earnings: 0JAX has high quality earnings.

Growing Profit Margin: 0JAX's current net profit margins (7.7%) are higher than last year (6.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0JAX's earnings have grown by 16.6% per year over the past 5 years.

Accelerating Growth: 0JAX's earnings growth over the past year (13.4%) is below its 5-year average (16.6% per year).

Earnings vs Industry: 0JAX earnings growth over the past year (13.4%) exceeded the Chemicals industry -13%.


Return on Equity

High ROE: 0JAX's Return on Equity (11.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innospec Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jonathan TanwantengCJS Securities, Inc.
David SilverCL King & Associates, Inc.
Sean MilliganJohnson Rice & Company, L.L.C.